Groundbreaking Discovery in Vaccine Research: Novel Adjuvant PVP-037 Shows Promise

Groundbreaking discovery in vaccine research: Precision Vaccines Program at Boston Children’s Hospital identifies novel adjuvant, PVP-037, to enhance immune responses. Dr Levy describes PVP-037 as ‘rocket fuel for the immune system’, showing superior efficacy. Screening over 200,000 small molecules led to this potent immunomodulator, offering promise for more effective vaccines in the future.